Immunoglobulin immobilized liposomal constructs for transmucosal vaccination through nasal route

Journal of Liposome Research

Volumn 21, Issue 3, 2011, Pages 181-193

  Tiwari, Brajesh ^a   Agarwal, Abhinav ^a   Kharya, Anil K ^a   Lariya, Narendra ^a   Saraogi, Gauravkant ^a   Agrawal, Himanshu ^b   Agrawal, Govind P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

HBsAg; IgG; Immunoglobulin; Liposome; M cells

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; LIPOSOME;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; VACCINATION; ZETA POTENTIAL;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG CARRIERS; FEMALE; HEPATITIS B SURFACE ANTIGENS; IMMUNOGLOBULIN G; LIPOSOMES; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; MUCOUS MEMBRANE; VACCINATION;

EID: 80051734175     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2010.498003     Document Type: Article

References (49)

1. Abraham, E. (1992). Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 107:461-468.
2. Alcon, V. L., Baca-Estrada, M., Vega-López, M. A., Willson, P, Babiuk, L. A., Kumar, P., et al. (2005). Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model. J Pharm Pharmacol 57:955-962.
3. Adler, A. J., Greenfield, N. J., Fasman, G. D. (1973). Circular dichroism and optical rotator dispersion of proteins and polypeptides. Meth Enzymol 27:675-735.
4. Bersted, A. K. H., Anderson, S. R., Delseg, R., Dromtorp, S., Holst, J., Namork, E. (2000). Inactivated meningococci and pertissis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus. Vaccine 18:1910-1919.
5. Chen, H., Jiang, J. H., Li, Y. F., Deng, T., Shen, G. L., Yu, R. Q. (2007). A novel piezoelectric immunoagglutination assay technique with antibody-modified liposome. Biosens Bioelectron 22:993-999.
6. Chiou, C. J., Tseng, L. P., Deng, M. C., Jiang, P. R., Tasi, S. L., Chung, T. W., et al. (2009). Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials 30:5862-5868.
7. Clark, M. A., Hirst, B. H., Jepson, M. A. (2000). Lectin-mediated mucosal delivery of drugs and microparticles. Adv Drug Deliv Rev 432:207-223.
8. Dapergolas, G., Gregoriadis, G. (1976). Oral administration of insulin by encapsulation within liposomes. Lancet 2:824-827.
9. Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Sperandio, S., Melber, K. (2002). Intranasal immunization with recombinant antigens associated with new cationic particle induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 20:2752-2763.
10. Drury, R. A. B., Wallington, E. A., Cameron, R. (1976). Carleton's histological technique, 4th ed (pp 114-137). Oxford, UK: Oxford University Press.
11. Elbayoumi, T. A., Torchilin, V. P. (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody, 2C5, in various tumours in mice: Gammaimaging studies. Eur J Nucl Med Mol Imaging 33:1196-1205.
12. Elbayoumi, T. A., Torchilin, V. P. (2007). Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicinloaded PEGylated liposomes against various tumor cell lines. Eur J Pharm Sci 3:159-168.
13. Ermak, T. H., Giannasca, P. J. (1998). Microparticle targeting to M cells. Adv Drug Deliv Rev 342:261-283.
14. Frézard, F. (1999). Liposomes: From biophysics to the design of peptide vaccines. Braz J Med Biol Res 322:181-189.
15. Fry, D. W., White, J. C., Goldman, I. D. (1978). Rapid separation of low molecular weight solute from liposomes without dilution. Anal Biochem 90:809-815.
16. Gupta, P. N., Mahor, S., Rawat, A., Khatri, K., Goyal, A., Vyas, S. P. (2006). Non-invasive vaccine delivery in transferrosomes, niosomes and liposomes: A comparative study. Int J Pharm 318:163-173.
17. Gupta, R. K., Rost, B. E. (1999). Aluminum compounds as vaccine adjuvants. Meth Mol Med 42:65-89.
18. Haan, A. D., Geerligs, H. J., Huchshorn, J. P., Scharrenburg, G. J. M. V., Palache, A. M., Wilschut, J. (1995). Mucosal immunoadjuvent activity of liposomes: Induction of systemic IgG and secretary IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 132:155-162.
19. Harokopakis, E., Childers, N. K., Michalek, S. M., Zhang, S. S., Tomasi, M. (1995). Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J Immunol Meth 1851:31-42.
20. Harokopakis, E., Hajishengallis, G., Michalek, S. M. (1998). Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect Immun 669:4299-4304.
21. Hemker, H. C., Hermans, W. T., Muller, A. D., Zawal, R. F. A. (1980). Oral treatment of hemophilia by a gastrointestinal absorption of factor VIII entrapped in liposomes. Lancet 1:70-71.
22. Jaganathan, K. S., Vyas, S. P. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24:4201-4211.
23. Jain, S., Sharma, R. K., Vyas, S. P. (2006a). Chitosan nanoparticles encapsulated vesicular systems for oral immunization: Preparation, in vitro, and in vivo characterization. J Pharm Pharmacol 58:303-310.
24. Jain, S., Vyas, S. P. (2006b). Mannosylated niosomes as adjuvantcarrier system for oral mucosal immunization. J Liposome Res 16:331-345.
25. Kool, M., Soullie, T., Nimwegen, M. V., Willart, M. A. M., Muskens, F., Jung, S., et al. (2008). Alum adjuvant boost adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2054:869-882.
26. McGhee, J. R., Lamm, M. E., Strober, W. (1999). Mucosal immune responses. In: Ogra, P. L., Mestecky, J., Lamm, M. E., Strober, W., Bienenstock, J., et al. (Eds.), Mucosal immunology, vol. 2 (pp 485-506). San Diego, California, USA: Academic Press.
27. Nakane, A., Numata, A., Minagawa, T. (1992). Tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun 60:523-528.
28. Nakano, Y., Mori, M., Nishinohra, S., Takita, Y., Naito, S., Kato, H., et al. (2001). Surface-linked liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes. Bioconj Chem 12:48-53.
29. Neutra, M. R, Kraehenbuhl, J. P. (1992). Transepithelial transport and mucosal defense. I: The role of M cells. Trends Cell Biol 2:134-138.
30. Patel, H. M., Rayman, B. E. (1976). Oral administration of insulin by encapsulation within liposomes. FEBS Lett 62:60-63.
31. Porta, C., James, P. S., Phillips, A. D., Savidge, T. C., Smith, M. W., Cremaschi, D. (1992). Confocal analysis of fluorescent bead uptake by mouse Peyer's patches. Exp Physiol 77:929-932.
32. Rai, S., Paliwal, R., Vaidya, B., Khatri, K., Goyal, A. K., Gupta, P. N., et al. (2008). Targeted delivery of doxorubicin via estrone-appended liposomes. J Drug Targ 16:455-463.
33. Ramyen, B. E., Jewkes, R. F., Jeyasingh, K., Osborne, M. P., Patel, H. M., Richardson, V. J., et al. (1978). Potential applications of liposomes to therapy. Ann N Y Acad Sci 308:281-307.
34. Saraf, S., Mishra, D., Asthana, A., Jain, R., Singh, S, Jain, N. K. (2006). Lipid microparticles for mucosal immunization against hepatitis B. Vaccine 24:45-56.
35. Shukla, A., Katare, O. P., Singh, B., Vyas, S. P. (2010). M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm 385:47-52.
36. Singh, P., Prabakaran, D., Jain, S., Mishra, V., Jaganathan, K. S., Vyas, S. P. (2004). Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm 278:379-390.
37. Sjolander, S., Drane, D., Davis, R., Beezum, L., Pearse, M., Cox, J. (2001). Intranasal immunization with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine 19:4072-4080.
38. Smirnov, V. N., Domogatsky, S. P., Dolgov, V. V., Hvatov, V. B., Klibanov, A. L., Koteliansky, V. E., et al. (1986). Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A 83:6603-6607.
39. Smith, M. W., Thomas, N. W., Jenkins, P. G., Miller, N. G. A., Cremaschi, D., Porta, C. (1995). Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp Physiol 80:735-743.
40. Spreng, S., Dietrich, G., Weidinger, G. (2006). Rational design of Salmonella-based vaccination strategies. Methods 38:133-143.
41. Tiwari, S., Goyal, A. K., Mishra, N., Khatri, K., Vaidya, B., Mehta, A., et al. (2009) Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Contr Rel 140:157-165.
42. Tizard, I. R. (2004). Immunology: An introduction, 4th ed (p 73). Singapore: Thomson Pte. Ltd.
43. Torchilin, V. P., Khaw, B. A., Smirnov, V. N., Haber, E. (1979). Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophy Res Commun 894: 1114-1119.
44. Utreja, S., Jain, N. K. (2001). Solid lipid nanoparticles. In: Jain, N. K. (Ed.), Advances in controlled and novel drug delivery, 1st ed. (pp 408-424). New Delhi, India: CBS Publishers and Distributors.
45. Vajdy, M., O'Hangan, D. T. (2001). Microparticles for intranasal immunization. Adv Drug Del Rev 51:127-141.
46. Velez, C. N., Tonkonogy, S. L., Lichtman, S. N., Cho, M. J. (1997). Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity. J Drug Targ 5:15-24.
47. Wang, D., Christopher, M. E., Nagata, L. P., Zabielski, M. A., Li, H., Wong, J. P. (2004). Intranasal immunization with liposome encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular, and humoral immune responses. Clin Virol 31:99-106.
48. Yuki, Y., Kiyono, H. (2003). New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 13:293-310.
49. Zhou, F., Kraehenbuhl, J. P., Neutra, M. R. (1995). Mucosal IgA response to rectally administered antigen formulated in IgAcoated liposomes. Vaccine 137:637-644.